Generic Omnicef
 |
Active component:
CefdinirPackages: 300 mg |
Omnicef (Cefdinir) 300 mg buy online at our online pharmacy: | ||
| Package | Price | Currency: |
|---|---|---|
| Omnicef 300 mg × 180 pills | $ 797.30 $ 575.90 $ 3.20 per pill | Buy Omnicef 300 mg × 180 » |
| Omnicef 300 mg × 120 pills | $ 532.10 $ 404.90 $ 3.37 per pill | Buy Omnicef 300 mg × 120 » |
| Omnicef 300 mg × 90 pills | $ 398.80 $ 325.90 $ 3.62 per pill | Buy Omnicef 300 mg × 90 » |
| Omnicef 300 mg × 60 pills | $ 265.70 $ 233.90 $ 3.90 per pill | Buy Omnicef 300 mg × 60 » |
| Omnicef 300 mg × 30 pills | $ 140.90 $ 132.90 $ 4.43 per pill | Buy Omnicef 300 mg × 30 » |
We accept major debit cards, credit cards and pre-paid credit cards: Visa, MasterCard and other
Manufacturer: Ranbaxy Laboratories Ltd., Torrent Pharmaceuticals Limited
Omnicef is a semi-synthetic β-laktamnah antibiotic that exhibits a bactericidal effect due to inhibition of cell wall synthesis of bacteria. Cefdinir acts on many organisms producing β-lactamase and are resistant to penicillins and other cephalosporins.
Cefdinir active against most strains of the following microorganisms, both "in vitro" and in clinical practice: aerobic gram-positive microorganisms: Staphylococcus aureus (including strains producing β-lactamase), Streptococcus pneumoniae (only the strains sensitive to penicillin), Streptococcus pyogenes, aerobic gram-negative microorganisms: Haemophilus influenzae (including strains producing β-lactamases), Haemophilus parainfluenzae (including strains producing β-lactamases), Moraxella catarrhalis (including strains producing β-lactamases).
Cefdinir (omnicef online) inactive against Pseudomonas aeruginosa, Enterobacter spp., Enterococcus spp. and methicillin-resistant Staphylococcus spp.
Infectious-inflammatory diseases of mild to moderate severity, caused by sensitive microorganisms: infections of the respiratory tract, acute sinusitis, acute otitis media, pharyngitis, tonsillitis, infections of the lower respiratory tract, exacerbation of chronic bronchitis, community acquired pneumonia, uncomplicated skin infections and soft tissue.
Cefdinir active against most strains of the following microorganisms, both "in vitro" and in clinical practice: aerobic gram-positive microorganisms: Staphylococcus aureus (including strains producing β-lactamase), Streptococcus pneumoniae (only the strains sensitive to penicillin), Streptococcus pyogenes, aerobic gram-negative microorganisms: Haemophilus influenzae (including strains producing β-lactamases), Haemophilus parainfluenzae (including strains producing β-lactamases), Moraxella catarrhalis (including strains producing β-lactamases).
Cefdinir (omnicef online) inactive against Pseudomonas aeruginosa, Enterobacter spp., Enterococcus spp. and methicillin-resistant Staphylococcus spp.
Infectious-inflammatory diseases of mild to moderate severity, caused by sensitive microorganisms: infections of the respiratory tract, acute sinusitis, acute otitis media, pharyngitis, tonsillitis, infections of the lower respiratory tract, exacerbation of chronic bronchitis, community acquired pneumonia, uncomplicated skin infections and soft tissue.
Technical Information
Brand names: Ancef, Biofuroksym, Ceclor, Cedax, Cefditoren, Cefizox, Cefobid, Cefotan, Ceftin, Cefurax, Cefuril, Cefuroxim, Cefuroximo, Cefuroximum, Cefzil, Cepazine, Cephuroxime, Ceptaz, Duricef, Elobact, Fortaz, Gruencef, Keflex, Keftab, Kefurox, Kefzol, Kerurox, Mandol, Maxipime, Mefoxin, Monocid, Oraxim, Rocephin, Sharox, Tazicef, Vantin, Velosef, Zinacef, Zinat, Zinnat
Omnicef: Cefdiel (Ranbaxy Laboratories Ltd.), Adcef (Torrent Pharmaceuticals Limited)
Imprints: Omnicef (cefdinir) OMNICEF 300 mg a